Multicenter Phase II Trial of Oxaliplatin and Docetaxel for Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck.

Trial Profile

Multicenter Phase II Trial of Oxaliplatin and Docetaxel for Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Nov 2013

At a glance

  • Drugs Docetaxel; Oxaliplatin
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Aug 2011 Planned End Date changed from 1 Dec 2010 to 1 Nov 2009 as reported by ClinicalTrials.gov.
    • 20 Jan 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 01 Jul 2009 Planned end date changed from 1 Mar 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top